Back to search results

Solution-Focused Brief Therapy for Adolescent and Young Adult Cancer Survivors

This study is looking at how well a type of talk therapy called Solution-Focused Brief Therapy for Cancer Survivors (SFBT-C) helps young people (ages 15-39) who have had cancer and are feeling stressed or anxious. This therapy is given virtually, meaning you can do it from home. The study will compare SFBT-C to standard care, which includes educational materials and check-in calls. Researchers want to see if SFBT-C can reduce psychological distress (feelings of sadness, anxiety, or stress) in cancer survivors. You might be able to join if you are 15-39 years old, have been diagnosed with cancer, are currently receiving care or finished treatment within the last five years, are experiencing psychological distress, and speak English fluently. The study aims to enroll 60 participants.

Study design
This is an interventional study comparing Solution-Focused Brief Therapy for Cancer Survivors (SFBT-C) to enhanced standard care, with a planned enrollment of 60 participants.
What's involved
You would participate in SFBT-C or receive educational materials and check-in calls, and engage in discussions. Your psychological distress will be measured at the start, immediately after the intervention, and then 4 and 8 weeks later.
Compensation
Not stated in the trial record.
Follow-up
Participants will be followed for 8 weeks after the intervention ends.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT06941324

Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors

Recruiting
NAAges 15–39InterventionalSupportive care
University of Michigan Rogel Cancer Center
~60 participants
Updated 2026-07-16 on ClinicalTrials.gov
What's tested:Behavioral InterventionBest PracticeCommunication InterventionDiscussionHealth Promotion and EducationInterview

At a glance

Recruiting sites
1 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Efficacy of solution-focused brief therapy in cancer survivors (SFBT-C)
Measured over At baseline, immediate post-intervention, and 4 and 8 weeks post-intervention

Conditions

Hematopoietic and Lymphatic System Neoplasm
Malignant Solid Neoplasm

Explore related trials

Hematologic NeoplasmSolid Neoplasm

NCT06941324

Where you'd take part

This study runs at 1 site. They're the same protocol — you choose where, and that choice sets who your contact draft is addressed to.

  • University of Michigan Comprehensive Cancer Center

    Ann Arbor, Michiganstudy coordinator listed

    Recruiting

Sites open and close at different times, so the status above is per site — it can differ from the study's overall status.

Study leadership

  • Sunnye Mayes · PRINCIPAL_INVESTIGATOR · University of Michigan Rogel Cancer Center

Who to contact

Cancer AnswerLine
[email protected]
1-800-865-1125
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Want this trial checked against your situation?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

15 - 39 years old
Diagnosed with cancer
Receiving active cancer care (6 weeks post initial diagnosis to control for emotional responses to normative stressors) or within 5 years of post-treatment survivorship
Experiencing psychological distress (i.e., a t-score \>= 57 on the Brief Symptom Inventory - 18 items \[BSI-18\])
Fluent in English

Exclusion

End-of-life care
\> 5 years into the post-treatment survivorship
Major physical challenges (e.g., hearing loss, developmental delay)
Acute mental health conditions (e.g., active psychosis, suicide risk)
Receiving or newly initiated psychotherapy for psychological distress during the study period

What this trial measures

  • Efficacy of solution-focused brief therapy in cancer survivors (SFBT-C)At baseline, immediate post-intervention, and 4 and 8 weeks post-intervention

    The primary analysis will be a linear regression model with the change score from baseline (T1) to 4 weeks post-intervention completion (T3) in participants' Brief Symptom Inventory, 18-item (BSI-18) t-score as the dependent variable, the intervention assignment, and the randomization strata (age and sex) as the independent variables, i.e., covariates to control for.